T1	Participants 82 266	In a randomized multicenter study, the efficacy and safety of cefprozil were compared with those of penicillin in the treatment of group A streptococcal tonsillopharyngitis in children
T2	Participants 268 443	Of the 409 patients enrolled, 323 were evaluable for their clinical and bacteriological responses; of these 323 children, 172 received cefprozil and 151 received penicillin V.
T3	Participants 1392 1504	Cefprozil can be considered a safe and reliable drug for the treatment of streptococcal pharyngitis in children.
